Clinical Trial

Daily Tadalafil in Diabetic ED Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2025 (before its estimated August 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates the effect of 5 mg daily tadalafil therapy on serum levels of Endothelin-1 and E-selectin in diabetic male patients with erectile dysfunction. Outcomes will be compared pre- and post-treatment versus healthy controls.
Trial Details
NCT Number NCT06962462
Lead Sponsor South Valley University
Conditions Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
Enrollment 60 participants
Start Date 2025-05-05
Primary Completion 2025-08-05 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-08